Ezdiatech Inc.

Ezdiatech Inc. started its journey to overcome the limitations of existing methods for Traumatic Brain Injury (concussion) which is one of the common injuries globally using the "VEUS System" and to consider a method to diagnose easily in the emergency room and in small and medium-sized hospitals. Limitations of existing testing: 1. low sensitivity (below 10%) of CT scans 2. The risk of radiation exposure from CT 3. A long diagnosis time for CT As a result, Ezdiatech Inc. has developed a Traumatic Brain Injury diagnostic kit (VEUPLEX TBI assay) and platform fully automatic diagnostic instrument (VEUDx) to meet the needs of customers who want to use new, more accurate, and secure testing methods easily. "VEUS System," a precision quantitative system is contained by 4 new technologies as below. 1. Ingenious giant magnetic particle technology 2. Magnetic particle Moving Control Reaction Technology 3. Ultra-high-sensitivity fluorescence image detection technology 4. A.I multiple diagnostic analysis technology These days, the demand for a diagnostic system with high accuracy for new biomarkers that can be applied in research for various biomarkers, make multiplexed quantity possible within 15~60min, and produce a precise diagnosis is increasing steadily. VEUDx is also an "innovative next-generation biomarker (protein) quantification system" that combines these technologies to produce rapid, multiple, and accurate quantitative results in less than 15 to 60 minutes. Furthermore, Ezdiatech Inc. is continually proceeding with research and development to diagnose neurological diseases such as Alzheimer's and stroke, which are on the rise with global aging using platform diagnostic instruments. Finally, Ezdiatech Inc. always tries to take a step forward to meet the needs of our customers.

• Employees 2
• Founded 2016